Israeli data show that a joint vaccine between Pfizer and BioNTech prevents not only disease but also coronavirus transmission, Bloomberg writes. This is very good news because it can significantly slow down the spread of the epidemic if vaccinated people are protected not only from the disease but also from being able to transmit the virus asymptomatically.
To see the exact numbers: Pfizer showed a success rate of 89.4 percent for laboratory-confirmed infections, although the study proving this has not yet been approved by an independent scientific advisory board and has not been published in a scientific journal – it has only started circulating on Twitter , and its validity was confirmed by a local researcher. Nevertheless, several international researchers questioned its credibility. It is also worth noting that the study writes about observational research, which is always a little more inaccurate than traditional duplicate, controlled experiments, but it is unethical to perform these in the case of coronavirus.
Pfizer and BioNTech have already indicated that they are processing Israeli data and are also interpreting it, this work is already underway. However, they did not wish to comment on this case.
#Pfizer #vaccine #appears #inhibit #coronavirus #transmission
